Neuronetics

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Neuronetics and other ETFs, options, and stocks.

About STIM

Neuronetics, Inc. is a commercial stage medical technology company, which focuses on designing, developing and marketing products that improve the quality of life for patients who suffer from neurohealth disorders. It operates through United States and International geographical segments. 

CEO
Daniel L. Reuvers
CEODaniel L. Reuvers
Employees
658
Employees658
Headquarters
Malvern, Pennsylvania
HeadquartersMalvern, Pennsylvania
Founded
1998
Founded1998
Employees
658
Employees658

STIM Key Statistics

Market cap
99.10M
Market cap99.10M
Price-Earnings ratio
-3.81
Price-Earnings ratio-3.81
Dividend yield
—
Dividend yield—
Average volume
5.25M
Average volume5.25M
High today
$1.35
High today$1.35
Low today
$1.25
Low today$1.25
Open price
$1.34
Open price$1.34
Volume
579.34K
Volume579.34K
52 Week high
$3.44
52 Week high$3.44
52 Week low
$0.80
52 Week low$0.80

Stock Snapshot

The current Neuronetics(STIM) stock price is $1.28, with a market capitalization of 99.1M. The stock trades at a price-to-earnings (P/E) ratio of -3.81.

On 2026-11-19, Neuronetics(STIM) stock traded between a low of $1.25 and a high of $1.35. Shares are currently priced at $1.28, which is +2.0% above the low and -5.6% below the high.

Neuronetics(STIM) shares are trading with a volume of 579.34K, against a daily average of 5.25M.

During the past year, Neuronetics(STIM) stock moved between $0.80 at its lowest and $3.44 at its peak.

During the past year, Neuronetics(STIM) stock moved between $0.80 at its lowest and $3.44 at its peak.

STIM News

Zacks 2d
Neuronetics Loses 34.6% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner

Neuronetics (STIM Quick QuoteSTIM - Free Report) has been beaten down lately with too much selling pressure. While the stock has lost 34.6% over the past...

Neuronetics Loses 34.6% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner
Investing.com 3d
William Blair initiates Neuronetics stock at Outperform on strategy shift - Investing.com

...

William Blair initiates Neuronetics stock at Outperform on strategy shift - Investing.com
TipRanks 3d
Neuronetics initiated with an Outperform at William Blair

William Blair analyst Steven Lichtman initiated coverage of Neuronetics (STIM) with an Outperform rating. Under new senior leadership, Neuronetics has initiated...

More STIM News

TipRanks 5d
Neuronetics Earnings Call Signals Stronger Growth and Margins

Neuronetics ((STIM)) has held its Q3 earnings call. Read on for the main highlights of the call. Neuronetics delivered a largely positive third quarter, combin...

People also own

Based on the portfolios of people who own STIM. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.